CD24 and breast cancer: We found that absence of glycosylation at N52 results in loss of peripheral CD24 in MDA-MB-231 and Hs578T breast cancer cells, as well as in HEK293T cells, reminiscent of what we observe for endogenous CD24 in these cells.